Industry Reports
Abbott reports strong second quarter results
Abbott announced financial results for the second quarter ended June 30, 2012. Diluted earnings per share, excluding specified items, were $1.23, reflecting 9.8 percent growth, exceeding Abbott's guidance range. Diluted earnings per share under Generally Accepted Accounting Principles...
Industry Reports
Ironwood Pharmaceuticals Provides Second Quarter 2012 Investor Update Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals, Inc. today provided an update on its second quarter 2012 and recent business activities. Second Quarter 2012 and Recent Highlights Linaclotide In April, the U.S. Food and Drug Administration (FDA) notified Ironwood...
Industry Reports
Merck total revenues increase 3.2% to € 2.6 billion
The Merck Group's first-quarter 2012 total revenues rose 3.2% to € 2,645 million compared to € 2,564 million in the first quarter of 2011. Sales for the Group increased 3.5% to € 2,564 million in first quarter compared...
Industry Reports
Infinity Reports First Quarter 2012 Financial Results
Infinity Pharmaceuticals, Inc.today reported its financial results for the first quarter of 2012. The company maintained its strong financial condition while continuing to advance its clinical programs during the quarter toward the key development milestones expected in the...
Industry Reports
Pfizer reports first-quarter 2012 results
Pfizer Inc. today reported financial results for first-quarter 2012. First-quarter 2012 revenues were $15.4 billion, a decrease of 7% compared with $16.5 billion in the year-ago quarter, which reflects an operational decline of $1.0 billion, or 6%, and...
Industry Reports
Revenue of first quarter 2012
ADOCIA, a biotechnology company specialized in the development of best-in-class medicines with already-approved therapeutic proteins, announces today revenues of EUR 1.2 million for the first quarter of 2012 compared to EUR 0.6 million for the same quarter last year. ...
Industry Reports
Pfizer reports fourth-quarter and full-year 2011 results
Pfizer Inc. reported financial results for fourth-quarter and full-year 2011. Fourth-quarter 2011 revenues were $16.7 billion, a decrease of 4% compared with $17.4 billion in the year-ago quarter, which reflects an operational decline of $765 million, or 5%, and the favorable...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read